| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |